Tivicay dolutegravir: Phase III started

ViiV began the identical, double-blind, international Phase III GEMINI 1 and 2 trials each in about 700 treatment-naive HIV patients to compare a once-daily oral regimen of 50 mg Tivicay plus 300 mg ...